These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 18043472)
1. Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis. Punnett A; Sung L; Price V; Das P; Diezi M; Doyle J; Dupuis LL Ther Drug Monit; 2007 Dec; 29(6):750-7. PubMed ID: 18043472 [TBL] [Abstract][Full Text] [Related]
2. Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation. Malard F; Szydlo RM; Brissot E; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Mohty M Biol Blood Marrow Transplant; 2010 Jan; 16(1):28-34. PubMed ID: 20053329 [TBL] [Abstract][Full Text] [Related]
3. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors. Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G Bone Marrow Transplant; 2003 Oct; 32(8):777-84. PubMed ID: 14520421 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A. Izumi N; Furukawa T; Sato N; Okazuka K; Tsukada N; Abe T; Yano T; Kurasaki T; Masuko M; Toba K; Takahashi M; Aizawa Y Bone Marrow Transplant; 2007 Nov; 40(9):875-80. PubMed ID: 17724440 [TBL] [Abstract][Full Text] [Related]
5. Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Barkholt L; Remberger M; Bodegård H; Ringdén O; Böttiger Y Bone Marrow Transplant; 2007 Oct; 40(7):683-9. PubMed ID: 17660840 [TBL] [Abstract][Full Text] [Related]
6. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies. Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547 [TBL] [Abstract][Full Text] [Related]
7. Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors. Mori T; Kato J; Shimizu T; Aisa Y; Nakazato T; Yamane A; Ono Y; Kunimoto H; Okamoto S Biol Blood Marrow Transplant; 2012 Feb; 18(2):229-34. PubMed ID: 21708109 [TBL] [Abstract][Full Text] [Related]
8. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study. Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G; Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759 [TBL] [Abstract][Full Text] [Related]
9. Effect of cyclophosphamide on serum cyclosporine levels at the conditioning of hematopoietic stem cell transplantation. Nagamura F; Takahashi T; Takeuchi M; Iseki T; Ooi J; Tomonari A; Uchimaru K; Takahashi S; Tojo A; Tani K; Asano S Bone Marrow Transplant; 2003 Dec; 32(11):1051-8. PubMed ID: 14625575 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors. Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G Bone Marrow Transplant; 2003 Nov; 32(9):881-7. PubMed ID: 14561988 [TBL] [Abstract][Full Text] [Related]
11. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549 [TBL] [Abstract][Full Text] [Related]
12. Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients. Caocci G; Baccoli R; Vacca A; Mastronuzzi A; Bertaina A; Piras E; Littera R; Locatelli F; Carcassi C; La Nasa G Exp Hematol; 2010 May; 38(5):426-33. PubMed ID: 20206661 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation]. Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621 [TBL] [Abstract][Full Text] [Related]
14. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292 [TBL] [Abstract][Full Text] [Related]
15. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation. Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951 [TBL] [Abstract][Full Text] [Related]
16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290 [TBL] [Abstract][Full Text] [Related]
17. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia. Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976 [TBL] [Abstract][Full Text] [Related]
18. Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level. Oshima K; Kanda Y; Nakasone H; Arai S; Nishimoto N; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M Am J Hematol; 2008 Mar; 83(3):226-32. PubMed ID: 17918253 [TBL] [Abstract][Full Text] [Related]
19. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [TBL] [Abstract][Full Text] [Related]
20. Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor. Kanda Y; Hyo R; Yamashita T; Fujimaki K; Oshima K; Onoda M; Mori T; Sakura T; Tanaka M; Sakai M; Taguchi J; Kurakawa M; Maruta A; Okamoto S; Sakamaki H; Am J Hematol; 2006 Nov; 81(11):838-44. PubMed ID: 16888784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]